TC-2216

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameTC-2216
Drug Alias NameTC-2216
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscle-type nicotinic acetylcholine receptor antagonists
TargetsMuscle-type nicotinic acetylcholine receptor
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCatalyst
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTargacept Inc
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A